Estrogen receptor-beta is a potential target for triple negative breast cancer treatment

Triple Negative breast cancer (TNBC) is a subtype of breast cancer that lacks the expression of estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor 2. TNBC accounts for 15-20% of all breast cancer cases but accounts for over 50% of mortality. We propose that Est...

Descripción completa

Detalles Bibliográficos
Autores principales: Austin, David, Hamilton, Nalo, Elshimali, Yahya, Pietras, Richard, Wu, Yanyuan, Vadgama, Jaydutt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188058/
https://www.ncbi.nlm.nih.gov/pubmed/30338035
http://dx.doi.org/10.18632/oncotarget.26089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188058/
https://www.ncbi.nlm.nih.gov/pubmed/30338035
http://dx.doi.org/10.18632/oncotarget.26089

Ejemplares similares